Target intelligence / Profile preview

KIF26B antisense RNA 2 (KIF26B-AS2)

Target
KIF26B-AS2
Molecular classification
Other (long noncoding RNA)
01

Overview

KIF26B antisense RNA 2 (KIF26B-AS2) is a presumed long noncoding RNA (lncRNA) transcribed antisense to the KIF26B gene, which encodes a kinesin superfamily protein essential for vertebrate development, cell adhesion, and implicated in multiple cancers and organogenesis[2][3][4][5][1]. There is currently no experimental evidence in the peer-reviewed literature for a biological function, disease association, or therapeutic potential of KIF26B-AS2, and it is not recognized as a therapeutic or diagnostic target. All relevant scientific and therapeutic data concern the protein-coding KIF26B gene, not its antisense lncRNA. Independent characterization of KIF26B-AS2 as a drug target has not been reported, and its molecular role, if any, remains unelucidated. Note: If your intent was the kinesin family protein KIF26B rather than its antisense lncRNA (KIF26B-AS2), please specify, as extensive information exists for the protein target KIF26B in development, cancer, and cell adhesion[2][3][4][5][1]. If so, a different mapping should be performed.

Other names
KIF26B-AS2

Beyond the preview

Go deeper on KIF26B antisense RNA 2 (KIF26B-AS2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on KIF26B antisense RNA 2 (KIF26B-AS2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call